Global Glucagon Injection Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
Page: 99
Published Date: 10 Aug 2023
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Glucagon Injection market size was valued at USD 591.6 million in 2022 and is forecast to a readjusted size of USD 880.1 million by 2029 with a CAGR of 5.8% during review period.
Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.
The Glucagon injection market is driven by the rising prevalence of diabetes and hypoglycemia, and the growing awareness of the importance of emergency treatment for severe low blood sugar episodes. Glucagon injections are life-saving emergency medications used to rapidly raise blood sugar levels in individuals experiencing severe hypoglycemia. The rise in the global diabetic population and the need for effective management of insulin-related conditions contribute to market growth as glucagon injections offer a crucial solution in emergency situations. Moreover, advancements in device design and the development of user-friendly glucagon delivery systems have improved the accessibility and ease of administration. However, the market also faces challenges, including the need for patient education on proper administration and storage of glucagon injections, and the complexity of the regulatory landscape for medical emergency medications. Additionally, addressing affordability and expanding access to glucagon injections in various regions can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer innovative and reliable glucagon injection solutions, collaborate with healthcare providers to promote awareness and training, and address the challenges to meet the increasing demand for effective and life-saving emergency treatments for hypoglycemia.
The Global Info Research report includes an overview of the development of the Glucagon Injection industry chain, the market status of Hospital (Vials, Prefilled), Pharmacy (Vials, Prefilled), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Glucagon Injection.
Regionally, the report analyzes the Glucagon Injection markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Glucagon Injection market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Glucagon Injection market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Glucagon Injection industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Vials, Prefilled).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Glucagon Injection market.
Regional Analysis: The report involves examining the Glucagon Injection market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Glucagon Injection market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Glucagon Injection:
Company Analysis: Report covers individual Glucagon Injection manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Glucagon Injection This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Pharmacy).
Technology Analysis: Report covers specific technologies relevant to Glucagon Injection. It assesses the current state, advancements, and potential future developments in Glucagon Injection areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Glucagon Injection market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Glucagon Injection market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Vials
Prefilled
Market segment by Application
Hospital
Pharmacy
Major players covered
Novo Nordisk
Eli Lilly
Fresenius Kabi
Torrent Labs
Amphastar Pharmaceuticals
Xeris Pharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Glucagon Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Glucagon Injection, with price, sales, revenue and global market share of Glucagon Injection from 2018 to 2023.
Chapter 3, the Glucagon Injection competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Glucagon Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Glucagon Injection market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Glucagon Injection.
Chapter 14 and 15, to describe Glucagon Injection sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Glucagon Injection
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Glucagon Injection Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Vials
1.3.3 Prefilled
1.4 Market Analysis by Application
1.4.1 Overview: Global Glucagon Injection Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Pharmacy
1.5 Global Glucagon Injection Market Size & Forecast
1.5.1 Global Glucagon Injection Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Glucagon Injection Sales Quantity (2018-2029)
1.5.3 Global Glucagon Injection Average Price (2018-2029)
2.1 Novo Nordisk
2.1.1 Novo Nordisk Details
2.1.2 Novo Nordisk Major Business
2.1.3 Novo Nordisk Glucagon Injection Product and Services
2.1.4 Novo Nordisk Glucagon Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Novo Nordisk Recent Developments/Updates
2.2 Eli Lilly
2.2.1 Eli Lilly Details
2.2.2 Eli Lilly Major Business
2.2.3 Eli Lilly Glucagon Injection Product and Services
2.2.4 Eli Lilly Glucagon Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Eli Lilly Recent Developments/Updates
2.3 Fresenius Kabi
2.3.1 Fresenius Kabi Details
2.3.2 Fresenius Kabi Major Business
2.3.3 Fresenius Kabi Glucagon Injection Product and Services
2.3.4 Fresenius Kabi Glucagon Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Fresenius Kabi Recent Developments/Updates
2.4 Torrent Labs
2.4.1 Torrent Labs Details
2.4.2 Torrent Labs Major Business
2.4.3 Torrent Labs Glucagon Injection Product and Services
2.4.4 Torrent Labs Glucagon Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Torrent Labs Recent Developments/Updates
2.5 Amphastar Pharmaceuticals
2.5.1 Amphastar Pharmaceuticals Details
2.5.2 Amphastar Pharmaceuticals Major Business
2.5.3 Amphastar Pharmaceuticals Glucagon Injection Product and Services
2.5.4 Amphastar Pharmaceuticals Glucagon Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Amphastar Pharmaceuticals Recent Developments/Updates
2.6 Xeris Pharmaceuticals
2.6.1 Xeris Pharmaceuticals Details
2.6.2 Xeris Pharmaceuticals Major Business
2.6.3 Xeris Pharmaceuticals Glucagon Injection Product and Services
2.6.4 Xeris Pharmaceuticals Glucagon Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Xeris Pharmaceuticals Recent Developments/Updates
3.1 Global Glucagon Injection Sales Quantity by Manufacturer (2018-2023)
3.2 Global Glucagon Injection Revenue by Manufacturer (2018-2023)
3.3 Global Glucagon Injection Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Glucagon Injection by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Glucagon Injection Manufacturer Market Share in 2022
3.4.2 Top 6 Glucagon Injection Manufacturer Market Share in 2022
3.5 Glucagon Injection Market: Overall Company Footprint Analysis
3.5.1 Glucagon Injection Market: Region Footprint
3.5.2 Glucagon Injection Market: Company Product Type Footprint
3.5.3 Glucagon Injection Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Glucagon Injection Market Size by Region
4.1.1 Global Glucagon Injection Sales Quantity by Region (2018-2029)
4.1.2 Global Glucagon Injection Consumption Value by Region (2018-2029)
4.1.3 Global Glucagon Injection Average Price by Region (2018-2029)
4.2 North America Glucagon Injection Consumption Value (2018-2029)
4.3 Europe Glucagon Injection Consumption Value (2018-2029)
4.4 Asia-Pacific Glucagon Injection Consumption Value (2018-2029)
4.5 South America Glucagon Injection Consumption Value (2018-2029)
4.6 Middle East and Africa Glucagon Injection Consumption Value (2018-2029)
5.1 Global Glucagon Injection Sales Quantity by Type (2018-2029)
5.2 Global Glucagon Injection Consumption Value by Type (2018-2029)
5.3 Global Glucagon Injection Average Price by Type (2018-2029)
6.1 Global Glucagon Injection Sales Quantity by Application (2018-2029)
6.2 Global Glucagon Injection Consumption Value by Application (2018-2029)
6.3 Global Glucagon Injection Average Price by Application (2018-2029)
7.1 North America Glucagon Injection Sales Quantity by Type (2018-2029)
7.2 North America Glucagon Injection Sales Quantity by Application (2018-2029)
7.3 North America Glucagon Injection Market Size by Country
7.3.1 North America Glucagon Injection Sales Quantity by Country (2018-2029)
7.3.2 North America Glucagon Injection Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8.1 Europe Glucagon Injection Sales Quantity by Type (2018-2029)
8.2 Europe Glucagon Injection Sales Quantity by Application (2018-2029)
8.3 Europe Glucagon Injection Market Size by Country
8.3.1 Europe Glucagon Injection Sales Quantity by Country (2018-2029)
8.3.2 Europe Glucagon Injection Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9.1 Asia-Pacific Glucagon Injection Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Glucagon Injection Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Glucagon Injection Market Size by Region
9.3.1 Asia-Pacific Glucagon Injection Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Glucagon Injection Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10.1 South America Glucagon Injection Sales Quantity by Type (2018-2029)
10.2 South America Glucagon Injection Sales Quantity by Application (2018-2029)
10.3 South America Glucagon Injection Market Size by Country
10.3.1 South America Glucagon Injection Sales Quantity by Country (2018-2029)
10.3.2 South America Glucagon Injection Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11.1 Middle East & Africa Glucagon Injection Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Glucagon Injection Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Glucagon Injection Market Size by Country
11.3.1 Middle East & Africa Glucagon Injection Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Glucagon Injection Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12.1 Glucagon Injection Market Drivers
12.2 Glucagon Injection Market Restraints
12.3 Glucagon Injection Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of Glucagon Injection and Key Manufacturers
13.2 Manufacturing Costs Percentage of Glucagon Injection
13.3 Glucagon Injection Production Process
13.4 Glucagon Injection Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Glucagon Injection Typical Distributors
14.3 Glucagon Injection Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Glucagon Injection Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Glucagon Injection Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 4. Novo Nordisk Major Business
Table 5. Novo Nordisk Glucagon Injection Product and Services
Table 6. Novo Nordisk Glucagon Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Novo Nordisk Recent Developments/Updates
Table 8. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 9. Eli Lilly Major Business
Table 10. Eli Lilly Glucagon Injection Product and Services
Table 11. Eli Lilly Glucagon Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Eli Lilly Recent Developments/Updates
Table 13. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 14. Fresenius Kabi Major Business
Table 15. Fresenius Kabi Glucagon Injection Product and Services
Table 16. Fresenius Kabi Glucagon Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Fresenius Kabi Recent Developments/Updates
Table 18. Torrent Labs Basic Information, Manufacturing Base and Competitors
Table 19. Torrent Labs Major Business
Table 20. Torrent Labs Glucagon Injection Product and Services
Table 21. Torrent Labs Glucagon Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Torrent Labs Recent Developments/Updates
Table 23. Amphastar Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Amphastar Pharmaceuticals Major Business
Table 25. Amphastar Pharmaceuticals Glucagon Injection Product and Services
Table 26. Amphastar Pharmaceuticals Glucagon Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Amphastar Pharmaceuticals Recent Developments/Updates
Table 28. Xeris Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 29. Xeris Pharmaceuticals Major Business
Table 30. Xeris Pharmaceuticals Glucagon Injection Product and Services
Table 31. Xeris Pharmaceuticals Glucagon Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Xeris Pharmaceuticals Recent Developments/Updates
Table 33. Global Glucagon Injection Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 34. Global Glucagon Injection Revenue by Manufacturer (2018-2023) & (USD Million)
Table 35. Global Glucagon Injection Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 36. Market Position of Manufacturers in Glucagon Injection, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 37. Head Office and Glucagon Injection Production Site of Key Manufacturer
Table 38. Glucagon Injection Market: Company Product Type Footprint
Table 39. Glucagon Injection Market: Company Product Application Footprint
Table 40. Glucagon Injection New Market Entrants and Barriers to Market Entry
Table 41. Glucagon Injection Mergers, Acquisition, Agreements, and Collaborations
Table 42. Global Glucagon Injection Sales Quantity by Region (2018-2023) & (K Units)
Table 43. Global Glucagon Injection Sales Quantity by Region (2024-2029) & (K Units)
Table 44. Global Glucagon Injection Consumption Value by Region (2018-2023) & (USD Million)
Table 45. Global Glucagon Injection Consumption Value by Region (2024-2029) & (USD Million)
Table 46. Global Glucagon Injection Average Price by Region (2018-2023) & (US$/Unit)
Table 47. Global Glucagon Injection Average Price by Region (2024-2029) & (US$/Unit)
Table 48. Global Glucagon Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 49. Global Glucagon Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 50. Global Glucagon Injection Consumption Value by Type (2018-2023) & (USD Million)
Table 51. Global Glucagon Injection Consumption Value by Type (2024-2029) & (USD Million)
Table 52. Global Glucagon Injection Average Price by Type (2018-2023) & (US$/Unit)
Table 53. Global Glucagon Injection Average Price by Type (2024-2029) & (US$/Unit)
Table 54. Global Glucagon Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 55. Global Glucagon Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 56. Global Glucagon Injection Consumption Value by Application (2018-2023) & (USD Million)
Table 57. Global Glucagon Injection Consumption Value by Application (2024-2029) & (USD Million)
Table 58. Global Glucagon Injection Average Price by Application (2018-2023) & (US$/Unit)
Table 59. Global Glucagon Injection Average Price by Application (2024-2029) & (US$/Unit)
Table 60. North America Glucagon Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 61. North America Glucagon Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 62. North America Glucagon Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 63. North America Glucagon Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 64. North America Glucagon Injection Sales Quantity by Country (2018-2023) & (K Units)
Table 65. North America Glucagon Injection Sales Quantity by Country (2024-2029) & (K Units)
Table 66. North America Glucagon Injection Consumption Value by Country (2018-2023) & (USD Million)
Table 67. North America Glucagon Injection Consumption Value by Country (2024-2029) & (USD Million)
Table 68. Europe Glucagon Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Europe Glucagon Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Europe Glucagon Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 71. Europe Glucagon Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 72. Europe Glucagon Injection Sales Quantity by Country (2018-2023) & (K Units)
Table 73. Europe Glucagon Injection Sales Quantity by Country (2024-2029) & (K Units)
Table 74. Europe Glucagon Injection Consumption Value by Country (2018-2023) & (USD Million)
Table 75. Europe Glucagon Injection Consumption Value by Country (2024-2029) & (USD Million)
Table 76. Asia-Pacific Glucagon Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 77. Asia-Pacific Glucagon Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 78. Asia-Pacific Glucagon Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 79. Asia-Pacific Glucagon Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 80. Asia-Pacific Glucagon Injection Sales Quantity by Region (2018-2023) & (K Units)
Table 81. Asia-Pacific Glucagon Injection Sales Quantity by Region (2024-2029) & (K Units)
Table 82. Asia-Pacific Glucagon Injection Consumption Value by Region (2018-2023) & (USD Million)
Table 83. Asia-Pacific Glucagon Injection Consumption Value by Region (2024-2029) & (USD Million)
Table 84. South America Glucagon Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 85. South America Glucagon Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 86. South America Glucagon Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 87. South America Glucagon Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 88. South America Glucagon Injection Sales Quantity by Country (2018-2023) & (K Units)
Table 89. South America Glucagon Injection Sales Quantity by Country (2024-2029) & (K Units)
Table 90. South America Glucagon Injection Consumption Value by Country (2018-2023) & (USD Million)
Table 91. South America Glucagon Injection Consumption Value by Country (2024-2029) & (USD Million)
Table 92. Middle East & Africa Glucagon Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 93. Middle East & Africa Glucagon Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 94. Middle East & Africa Glucagon Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 95. Middle East & Africa Glucagon Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 96. Middle East & Africa Glucagon Injection Sales Quantity by Region (2018-2023) & (K Units)
Table 97. Middle East & Africa Glucagon Injection Sales Quantity by Region (2024-2029) & (K Units)
Table 98. Middle East & Africa Glucagon Injection Consumption Value by Region (2018-2023) & (USD Million)
Table 99. Middle East & Africa Glucagon Injection Consumption Value by Region (2024-2029) & (USD Million)
Table 100. Glucagon Injection Raw Material
Table 101. Key Manufacturers of Glucagon Injection Raw Materials
Table 102. Glucagon Injection Typical Distributors
Table 103. Glucagon Injection Typical Customers
List of Figures
Figure 1. Glucagon Injection Picture
Figure 2. Global Glucagon Injection Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Glucagon Injection Consumption Value Market Share by Type in 2022
Figure 4. Vials Examples
Figure 5. Prefilled Examples
Figure 6. Global Glucagon Injection Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Glucagon Injection Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Pharmacy Examples
Figure 10. Global Glucagon Injection Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Glucagon Injection Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Glucagon Injection Sales Quantity (2018-2029) & (K Units)
Figure 13. Global Glucagon Injection Average Price (2018-2029) & (US$/Unit)
Figure 14. Global Glucagon Injection Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Glucagon Injection Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Glucagon Injection by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Glucagon Injection Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Glucagon Injection Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Glucagon Injection Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Glucagon Injection Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Glucagon Injection Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Glucagon Injection Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Glucagon Injection Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Glucagon Injection Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Glucagon Injection Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Glucagon Injection Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Glucagon Injection Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Glucagon Injection Average Price by Type (2018-2029) & (US$/Unit)
Figure 29. Global Glucagon Injection Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Glucagon Injection Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Glucagon Injection Average Price by Application (2018-2029) & (US$/Unit)
Figure 32. North America Glucagon Injection Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Glucagon Injection Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Glucagon Injection Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Glucagon Injection Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Glucagon Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Glucagon Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Glucagon Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Glucagon Injection Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Glucagon Injection Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Glucagon Injection Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Glucagon Injection Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Glucagon Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Glucagon Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Glucagon Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Glucagon Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Glucagon Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Glucagon Injection Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Glucagon Injection Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Glucagon Injection Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Glucagon Injection Consumption Value Market Share by Region (2018-2029)
Figure 52. China Glucagon Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Glucagon Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Glucagon Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Glucagon Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Glucagon Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Glucagon Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Glucagon Injection Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Glucagon Injection Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Glucagon Injection Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Glucagon Injection Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Glucagon Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Glucagon Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Glucagon Injection Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Glucagon Injection Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Glucagon Injection Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Glucagon Injection Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Glucagon Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Glucagon Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Glucagon Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Glucagon Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Glucagon Injection Market Drivers
Figure 73. Glucagon Injection Market Restraints
Figure 74. Glucagon Injection Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Glucagon Injection in 2022
Figure 77. Manufacturing Process Analysis of Glucagon Injection
Figure 78. Glucagon Injection Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Novo Nordisk Eli Lilly Fresenius Kabi Torrent Labs Amphastar Pharmaceuticals Xeris Pharmaceuticals
Related Reports
10 Aug 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
